Vimarsana
Biggest News Aggregation in the World

Page 9 - Brian Ritchie News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Brian Ritchie. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Brian Ritchie Today - Breaking & Trending Today

PolyPid Ltd. (NASDAQ:PYPD) Q4 2023 Earnings Call Transcript - Vimarsana News

PolyPid Ltd. (NASDAQ:PYPD) Q4 2023 Earnings Call Transcript

PolyPid Ltd. (NASDAQ:PYPD) Q4 2023 Earnings Call Transcript February 14, 2024 PolyPid Ltd. misses on earnings expectations. Reported EPS is $-3.97 EPS, expectations were $-2.17. PolyPid Ltd. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Greeting morning and welcome to […]

Source: yahoo.com
PolyPid Provides Corporate Update and Reports Fourth Quarter and Full Year 2023 Financial Results - Vimarsana News

PolyPid Provides Corporate Update and Reports Fourth Quarter and Full Year 2023 Financial Results

More Than 100 Patients Enrolled in Ongoing SHIELD II Phase 3 Trial of D-PLEX100 for the Prevention of Abdominal Colorectal Surgical Site Infections Unblinded Interim Analysis to be Conducted Once Approximately 400 Patients Complete Their 30-Day Follow-up; Top-line Results Expected in Second Half of 2024 New Preclinical Data Showed OncoPLEX Injected Intratumorally Reduced Tumor Volume and Improved Survival in New Animal Models Recent Successful $16 Million Financing Extends Company’s Cash Runway

Source: yahoo.com
Arrowhead Pharmaceuticals Reports Fiscal 2024 First Quarter Results - Vimarsana News

Arrowhead Pharmaceuticals Reports Fiscal 2024 First Quarter Results

- Conference Call and Webcast Today, February 6, 2024, at 4:30 p.m. ETPASADENA, Calif.--(BUSINESS WIRE)--$arwr--Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced financial results for its fiscal 2024 first quarter ended December 31, 2023. The Company is hosting a conference call today, February 6, 2024,...

'Early on, I decided that food would be a focus rather than, for example, drugs' - Vimarsana News

'Early on, I decided that food would be a focus rather than, for example, drugs'

People keep asking Violent Femmes’ Brian Ritchie why he moved from New York to Tasmania. The answer is simple: “Because I like it.”

Source: smh.com.au
Cidara Therapeutics Announces Approval of REZZAYO by the MHRA for the Treatment of Invasive Candidiasis in Adults - Vimarsana News

Cidara Therapeutics Announces Approval of REZZAYO by the MHRA for the Treatment of Invasive Candidiasis in Adults

The UK MHRA approval follows approvals by the U.S. FDA and the European CommissionCidara is entitled to receive a milestone payment of approximate...